Deanna M. Petersen, Chief Business Officer at AVROBIO joins Jason C. Foster on the new episode of Ori Spotlight. Having led mergers and acquisitions for some of the biggest names in biotech including Shire’s $4.2 billion acquisition of ViroPharma, Deanna is unquestionably a powerhouse leader in the space. Now, as the 4th employee at AVROBIO, she talks about how she built a pipeline of personalized gene therapies and some of the challenges she faced. The biggest? Chemistry, Manufacturing and Controls (CMC).
Learn more about Deanna M. Petersen | https://www.linkedin.com/in/dmpetersen/
Ori Biotech Ltd 2022 © All rights reserved. Oribiotech is registered in England and Wales. Company registration 09757696.
"*" indicates required fields
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |